supply-chain disruption — e.g. “Existe/n otro/s medicamento/s con los mismos principios activos y para la misma vía de administración.” (Spain)
Recent shortage history
Spain: resolved 27 Apr 2026 (began 12 Apr 2026)
Spain: resolved 18 Mar 2026 (began 2 Feb 2026)
Spain: resolved 21 Jan 2026 (began 2 Dec 2025)
Spain: resolved 7 Oct 2025 (began 26 Aug 2025)
Spain: resolved 5 Oct 2025 (began 2 Jan 2025)
Frequently asked questions
Is Rosuvastatina/Ezetimiba Teva currently in shortage?
Yes. As of the latest regulator updates, Rosuvastatina/Ezetimiba Teva has 2 active shortage notices across 1 country (Spain). Status is refreshed daily from official regulatory sources.
Why is Rosuvastatina/Ezetimiba Teva in shortage?
Regulators attribute the current Rosuvastatina/Ezetimiba Teva shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Rosuvastatina/Ezetimiba Teva shortage be resolved?
Regulator-estimated resolution dates currently range from 30 Jul 2026 to 24 Sept 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Rosuvastatina/Ezetimiba Teva shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Rosuvastatina/Ezetimiba Teva status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.